These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14939681)

  • 21. [The relation of in vitro conteben sensitivity to conteben therapy; a study on conteben resistant tuberculosis strains].
    VELTMAN G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 106(5):413-20. PubMed ID: 14925075
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transactions of the German Society for Tuberculosis (Committee on Chemotherapy); Main theme, Conteben therapy].
    Tuberkulosearzt; 1951 Jan; 5(1):45-50. PubMed ID: 14817859
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lung hemorrhage and its cause in conteben therapy].
    RADENBACH KL
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(2):150-63. PubMed ID: 14830565
    [No Abstract]   [Full Text] [Related]  

  • 24. [Binding capacity of serum iodine in pulmonary tuberculosis during treatment with TbI-698 (conteben); a contribution to the significance of unsaturated fatty acids and to the mechanism of the therapeutic action of TbI in pulmonary tuberculosis].
    JENTGENS H; BREDE HD
    Munch Med Wochenschr; 1950 Aug; 92(19-20):766-7. PubMed ID: 14775625
    [No Abstract]   [Full Text] [Related]  

  • 25. Observations on the effect of amithiozone (tibione) in selected tuberculous pulmonary lesions.
    CHILDRESS WG; NORMAN JW; OTT RH; SPAIN DM
    Am Rev Tuberc; 1952 Jun; 65(6):692-708. PubMed ID: 14924192
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on the concentration of PAS and TB 1 in the pleural effusion while undergoing respective treatment. II. On TB 1 (conteben)].
    KAWAI K
    Kekkaku; 1952 Aug; 27(8):397-401. PubMed ID: 13023835
    [No Abstract]   [Full Text] [Related]  

  • 27. [Examination of the resistance of conteben].
    JULLIEN W; RIST N; CALS S
    J Med Bord; 1951 Dec; 128(12):1080-2. PubMed ID: 14908363
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effects of permanent conteben medication on the stomach of the phthisic].
    FABIAN G
    Dtsch Gesundheitsw; 1952 Aug; 7(33):1050-6. PubMed ID: 13020455
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of pulmonary tuberculosis in Kenya Africans with thiacetazone.
    HAYNES WS
    East Afr Med J; 1952 Sep; 29(9):339-55. PubMed ID: 13010149
    [No Abstract]   [Full Text] [Related]  

  • 30. [Agranulocytosis in conteben therapy].
    KOESTER ED; PRIBILLA W
    Med Welt (Stuttg); 1951 Dec; 20(49):1548-50. PubMed ID: 14940645
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aqueous solutions of conteben for intra-cavitary injection].
    POLSTER W
    Tuberkulosearzt; 1950 Oct; 4(10):594-5. PubMed ID: 14788310
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of TB I/698 (conteben) on the excretion of ammonia, of fixed bases and of chlorine in urine of tuberculous children].
    HUNGERLAND H; KOSTER R; WALTHER M
    Klin Wochenschr; 1952 Jun; 30(23-24):562-3. PubMed ID: 12981833
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of two years experience with conteben (TBI/698) in the treatment of tuberculosis at the Freiburg (Breisgau) Medical Clinic and the St. Blasien Sanatorium].
    SCHAICH W; STADLER L; KEIDERLING W
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 104(6):465-514. PubMed ID: 14820733
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of conteben and vitamin D2 therapy on Mycobacterium tuberculosis; comparative investigations on the conteben sensitivity in vitro and the course of skin tuberculosis under conteben therapy].
    VELTMAN G
    Zentralbl Bakteriol Orig; 1952 Aug; 158(6):417-25. PubMed ID: 13006962
    [No Abstract]   [Full Text] [Related]  

  • 35. [New methods in the local treatment of large tuberculous caverns of the lung with conteben].
    PESCHKE J
    Tuberkulosearzt; 1950 Aug; 4(8):440-6. PubMed ID: 14776765
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of the otorhinolaryngological localizations of tuberculosis with thiosemicarbazones (conteben)].
    STACHOWSKY L
    Rev Sanid Asist Soc; 1955; 20(5-6):319-38. PubMed ID: 13350962
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypothyroidism and cerebral edema following combined treatment of tuberculosis with conteben (TB I 698) and p-amino-salicylic acid.
    BERGQVIST N; DE MARE O
    Acta Med Scand; 1952 Aug; 143(5):323-35. PubMed ID: 12976024
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sedimentation rate and pathergy in tuberculotics treated with thiosemicarbazone and streptomycin].
    CASCIO G; PURPURA R
    Pediatria (Napoli); 1953; 61(7-8):607-18. PubMed ID: 13120191
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combined conteben and PAS therapy of pulmonary tuberculosis].
    HANTSCHMANN L; WERNER R
    Arztl Wochensch; 1950 Jul; 5(29):525-8. PubMed ID: 15432230
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rare complications in conteben therapy of tuberculosis].
    STEYER HH
    Medizinische; 1953 Feb; 21(9):281-2. PubMed ID: 13071225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.